Research Solutions Announces Agreement With Fortune 500 Biopharma Company Valued at $1 Million
PR Newswire•11/11/2026•08:00 ET
0
Key Highlights
- ➤$1 million Scite agreement marks Research Solutions’ largest deal in company history
- ➤Fortune 500 biopharma deploys Scite enterprise-wide across all research groups
- ➤Agreement expands longstanding Article Galaxy relationship with full Scite deployment
- ➤Full Scite API access and additional datasets support customer internal AI tools
Expert Statements
Roy W. Olivier, President and Chief Executive Officer of Research Solutions
“Every large R&D organization we talk to is rebuilding their search and discovery tools, and every one of them has the same problem: their AI agents need trusted access to the scientific literature”
Roy W. Olivier, President and Chief Executive Officer of Research Solutions
“This agreement is the largest in our history, and it is not a one-off. It reflects demand we are seeing across our pipeline from companies that need to ground their systems in real evidence.”
Research Solutions Announces Agreement With Fortune 500 Biopharma Company Valued at $1 Million PR Newswire
Largest Deal in Company History Further Supports Accelerating Enterprise Demand for AI Access to Scientific Literature
Get started
Create a free account to read the full story.